Document Detail


Pharmacodynamics of amlodipine: hemodynamic effects and antianginal efficacy after atrial pacing.
MedLine Citation:
PMID:  2530869     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
The hemodynamic effects and antianginal efficacy of 10 mg amlodipine administered intravenously were assessed for 45 minutes in 18 subjects with stable angina pectoris. After amlodipine the heart rate was increased from 75 +/- 12 beats/min to 80 +/- 15 beats/min (p less than 0.05) for at least 15 minutes, with a decrease in systemic vascular resistance of 1091 +/- 205 to 815 +/- 390 dynes/sec/cm5 and a decrease in mean arterial pressure at 30 minutes from 99 +/- 11 to 91 +/- 10 (p less than 0.05). There was no change in dp/dt or dp/dt/IP or in cardiac output, wedge pressure, or pulmonary artery pressure. In the parallel placebo group (n = 8) there was no change in any of the hemodynamic parameters. Time to pacing-induced angina was increased in the treated group (n = 12) from 6 +/- 3.2 minutes before the dose to 8.2 +/- 4 minutes after the dose (p less than 0.01) compared to the control subjects who were given saline solution, in whom the time increased from 7 +/- 1.5 minutes before the dose to 7.5 +/- 2.2 minutes after the dose (n = 9). The double product at an equivalent pacing time to the initial onset of angina was reduced after therapy from 15,590 +/- 1490 to 14,100 +/- 1193 with a reduction in ST segment shift from 11.9 +/- 9.4 mm2 to 6.2 +/- 5.6 mm2 (p less than 0.05). Amlodipine after intravenous use has a vasodilator effect and also increases the anginal threshold without deleterious negative inotropic effects.
Authors:
K J Hogg; R S Hornung; W S Hillis; S Gupta; P Grant; S P Singh
Related Documents :
3283979 - Hemodynamic function in acute pancreatitis.
3158869 - Effect of acidosis on contractile function in the newborn rabbit heart.
22728949 - Effect of at1 receptor blockade on intermittent hypoxia-induced endothelial dysfunction.
10647859 - Diaphragm inhibition with positive pressure ventilation: quantification of mechanical e...
22628379 - Locally measured shear moduli of pulmonary tissue and global lung mechanics in mechanic...
22695479 - Sitting and supine esophageal pressures in overweight and obese subjects.
17328269 - Disparity between adjusted and actual opening cerebrospinal fluid pressure in a patient...
16299149 - Hypertensive retinopathy revisited: some answers, more questions.
12626969 - Leukotriene-mediated coronary vasoconstriction and loss of myocardial contractility evo...
Publication Detail:
Type:  Clinical Trial; Controlled Clinical Trial; Journal Article    
Journal Detail:
Title:  American heart journal     Volume:  118     ISSN:  0002-8703     ISO Abbreviation:  Am. Heart J.     Publication Date:  1989 Nov 
Date Detail:
Created Date:  1989-12-06     Completed Date:  1989-12-06     Revised Date:  2007-11-15    
Medline Journal Info:
Nlm Unique ID:  0370465     Medline TA:  Am Heart J     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  1107-13     Citation Subset:  AIM; IM    
Affiliation:
Department of Materia Medica, University of Glasgow, Stobhill General Hospital, Scotland.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Amlodipine
Angina Pectoris / diagnosis,  physiopathology,  prevention & control*
Calcium Channel Blockers
Cardiac Pacing, Artificial*
Coronary Disease / diagnosis
Electrocardiography
Female
Heart Catheterization
Hemodynamics / drug effects*
Humans
Male
Middle Aged
Nifedipine / analogs & derivatives*,  pharmacology
Chemical
Reg. No./Substance:
0/Calcium Channel Blockers; 21829-25-4/Nifedipine; 88150-42-9/Amlodipine

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  The pharmacokinetic profile of amlodipine.
Next Document:  Late ventricular dilatation in survivors of acute myocardial infarction.